UKBizDB.co.uk

CLINICAL TRIALS CONSULTANCY (CTS) LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Clinical Trials Consultancy (cts) Limited. The company was founded 7 years ago and was given the registration number 10965751. The firm's registered office is in BIRMINGHAM. You can find them at 34 Wycome Road, , Birmingham, . This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:CLINICAL TRIALS CONSULTANCY (CTS) LIMITED
Company Number:10965751
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:15 September 2017
End of financial year:31 March 2019
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:34 Wycome Road, Birmingham, United Kingdom, B28 9EL
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
27, Old Gloucester Street, London, United Kingdom, WC1N 3AX

Director15 September 2017Active
27, Old Gloucester Street, London, United Kingdom, WC1N 3AX

Secretary15 September 2017Active
27, Old Gloucester Street, London, United Kingdom, WC1N 3AX

Director15 September 2017Active

People with Significant Control

Mr Mohammed Ishaq
Notified on:15 September 2017
Status:Active
Date of birth:September 1979
Nationality:British
Country of residence:United Kingdom
Address:27, Old Gloucester Street, London, United Kingdom, WC1N 3AX
Nature of control:
  • Right to appoint and remove directors

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (2 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (11 months ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.